תוצאות חיפוש - Jin‐Ji Yang
- Showing 1 - 20 results of 54
- Go to Next Page
-
1
-
2
Multiple primary malignancies involving lung cancer מאת Feng Li, Wen‐Zhao Zhong, Feiyu Niu, Ning Zhao, Jin‐Ji Yang, Hong‐Hong Yan, Yi‐Long Wu
יצא לאור 2015Artigo -
3
-
4
Myocardial Extracellular Volume Fraction Measured by Cardiac Magnetic Resonance Imaging Negatively Correlates With Cardiomyocyte Breadth in a Healthy Porcine Model מאת Zhang, Shi-Jun, Chang, Di, Jin, Ji-Yang, Wang, Ya-Ling, Wang, Lin, Wang, Yuan-Cheng, Wang, Zhen, Ju, Shenghong
יצא לאור 2022Text -
5
Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance מאת Zhen Wang, Jin‐Ji Yang, Jie Huang, Junyi Ye, Xu‐Chao Zhang, Hai‐Yan Tu, Han Han‐Zhang, Yi‐Long Wu
יצא לאור 2017Artigo -
6
Osimertinib and Cabozantinib Combinatorial Therapy in an EGFR -Mutant Lung Adenocarcinoma Patient with Multiple MET Secondary-Site Mutations after Resistance to Crizotinib מאת Jin‐Hyoung Kang, Hua‐Jun Chen, Zheng Wang, Jing Liu, Bing Li, Tengfei Zhang, Zhenfan Yang, Yi‐Long Wu, Jin‐Ji Yang
יצא לאור 2017Artigo -
7
-
8
Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC מאת Mei-Mei Zheng, Yang-Si Li, Hai‐Yan Tu, Ben‐Yuan Jiang, Jin‐Ji Yang, Qing Zhou, Chong‐Rui Xu, Xiaorong Yang, Yi‐Long Wu
יצא לאור 2020Artigo -
9
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803) מאת Yi‐Long Wu, Caicun Zhou, Ying Cheng, Shun Lü, G.-Y. Chen, Cheng Huang, Yulu Huang, Hong‐Hong Yan, Shengxiang Ren, Yao-Bin Liu, Jin‐Ji Yang
יצא לאור 2012Artigo -
10
BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification מאת Ben‐Yuan Jiang, Xuchao Zhang, Jian Su, Wei Meng, Xue‐Ning Yang, Jin‐Ji Yang, Qing Zhou, Zhiyong Chen, Zhihong Chen, Zhi Xie, Shiliang Chen, Yi‐Long Wu
יצא לאור 2013Artigo -
11
Intervertebral disc regeneration using platelet-rich plasma-containing bone marrow-derived mesenchymal stem cells: A preliminary investigation מאת WANG, SHAN-ZHENG, JIN, JI-YANG, GUO, YU-DONG, MA, LIANG-YU, CHANG, QING, PENG, XIN-GUI, GUO, FANG-FANG, ZHANG, HAI-XIANG, HU, XIN-FENG, WANG, CHEN
יצא לאור 2016Text -
12
Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression מאת Xu‐Chao Zhang, Shirley Zhang, Xue‐Ning Yang, Jin‐Ji Yang, Qing Zhou, Lucy Yin, Shejuan An, Jia-Yin Lin, Shiliang Chen, Zhi Xie, Mike Zhu, Xiaolin Zhang, Yi‐Long Wu
יצא לאור 2010Artigo -
13
Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients מאת Si‐Yang Maggie Liu, Hao Sun, Jiaying Zhou, Guang‐Ling Jie, Zhi Xie, Yang Shao, Xian Zhang, Junyi Ye, Chunxiang Chen, Xu‐Chao Zhang, Qing Zhou, Jin‐Ji Yang, Yi‐Long Wu
יצא לאור 2020Artigo -
14
Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial מאת Qing Zhou, Jin‐Ji Yang, Zhihong Chen, Xu‐Chao Zhang, Hong‐Hong Yan, Chong‐Rui Xu, Jian Su, Hua‐Jun Chen, Hai‐Yan Tu, Wen‐Zhao Zhong, Xue‐Ning Yang, Yi‐Long Wu
יצא לאור 2016Artigo -
15
A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R מאת E‐E Ke, Qing Zhou, Qiuyi Zhang, Jian Su, Zhihong Chen, Xu‐Chao Zhang, Chong‐Rui Xu, Jin‐Ji Yang, Hai‐Yan Tu, Hong‐Hong Yan, Yichen Zhang, Feiyu Niu, Yi‐Long Wu
יצא לאור 2017Artigo -
16
Molecular characteristics and clinical outcomes of <i>EGFR</i> exon 19 indel subtypes to EGFR TKIs in NSCLC patients מאת Jian Su, Wen‐Zhao Zhong, Xu‐Chao Zhang, Ying Huang, Hong‐Hong Yan, Jin‐Ji Yang, Zhong‐Yi Dong, Zhi Xie, Qing Zhou, Xiao-sui Huang, Danxia Lu, Wenqing Yan, Yi‐Long Wu
יצא לאור 2017Artigo -
17
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status מאת Wen‐Zhao Zhong, Xue‐Ning Yang, Hong‐Hong Yan, Xu‐Chao Zhang, Jian Su, Zhihong Chen, Ri-Qiang Liao, Qiang Nie, Song Dong, Qing Zhou, Jin‐Ji Yang, Hai‐Yan Tu, Yi‐Long Wu
יצא לאור 2015Artigo -
18
The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC מאת Si‐Yang Maggie Liu, Lan-ying Gou, Anna Li, Na-Na Lou, Hongfei Gao, Jian Su, Jin‐Ji Yang, Xu‐Chao Zhang, Yang Shao, Zhong‐Yi Dong, Qing Zhou, Wen‐Zhao Zhong, Yi‐Long Wu
יצא לאור 2016Artigo -
19
Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status מאת She-Juan An, Zhi Hong Chen, Jian Su, Xu‐Chao Zhang, Wen-Zhao Zhong, Jin-Ji Yang, Qing Zhou, Xue-Ning Yang, Ling Huang, Ji-Lin Guan, Qiang Nie, Hong-Hong Yan, Tony Mok, Yi‐Long Wu
יצא לאור 2012Artigo -
20
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclit... מאת Yi‐Long Wu, Nagahiro Saijo, Sumitra Thongprasert, James Chih‐Hsin Yang, Baohui Han, Benjamin Margono, B. Chewaskulyong, Patrapim Sunpaweravong, Yuichiro Ohe, Yukito Ichinose, Jin‐Ji Yang, Tony Mok, Helen Young, Vincent Haddad, Yuri Rukazenkov, Masahiro Fukuoka
יצא לאור 2016Artigo
כלי חיפוש:
נושאים קשורים
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Biology
Cancer research
Epidermal growth factor receptor
Genetics
Gene
Chemotherapy
Adenocarcinoma
Gefitinib
Pathology
Clinical endpoint
Erlotinib
Mutation
Confidence interval
Gastroenterology
Hazard ratio
Immunotherapy
KRAS
Phases of clinical research
Randomized controlled trial
Cisplatin
Colorectal cancer
Environmental health
Malignant pleural effusion
Osimertinib
Population